THE CHOICE OF THE ANTIHYPERTENSIVE DRUG IN SPECIAL CONDITIONS: GENDER- AND AGE-RELATED DIFFERENCES
https://doi.org/10.18705/1607-419X-2014-20-4-232-237
Abstract
The articles reviews the main approaches to the hypertension management in young and elderly patients, in males and females with the emphasis on the management of hypertension in pregnancy based on the data from the worldwide guidelines by the Joint National Committee of the USA, European Society of Cardiology/European Society of Hypertension, American Society of Hypertension/International Society of Hypertension.
About the Authors
N. G. Avdonina
Federal Almazov Medical Research Centre, St Petersburg
Russian Federation
Corresponding author: Federal Almazov Medical Research Centre, 2 Akkuratov st., St Petersburg, Russia, 197341. Phone: +7(812)702–68–10. E-mail: avdonina@almazovcentre.ru (Natalia G. Avdonina, MD, a Researcher at the Laboratory of the Pathogenesis and Treatment of Hypertension of the Hypertension Research Department at the Federal Almazov Medical Research Centre
Russian Federation
Corresponding author: Federal Almazov Medical Research Centre, 2 Akkuratov st., St Petersburg, Russia, 197341. Phone: +7(812)702–68–10. E-mail: avdonina@almazovcentre.ru (Natalia G. Avdonina, MD, a Researcher at the Laboratory of the Pathogenesis and Treatment of Hypertension of the Hypertension Research Department at the Federal Almazov Medical Research Centre
L. S. Korostovtseva
Federal Almazov Medical Research Centre, St Petersburg
Russian Federation
Russian Federation
O. B. Irtyuga
Federal Almazov Medical Research Centre, St Petersburg
Russian Federation
Russian Federation
N. E. Zvartau
Federal Almazov Medical Research Centre, St Petersburg
Russian Federation
Russian Federation
A. O. Konradi
Federal Almazov Medical Research Centre, St Petersburg
Russian Federation
Russian Federation
References
1. James P.A., Oparil S., Carter B.L. et al. 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8) // J. Am. Med. Assoc. — 2014. Vol. 311, № 5. — Р. 507–520. doi:10.1001/jama.2013.284427
2. Weber M.A., Schiffrin E.L., White W.B. et al. Clinical practice guidelines for the management of hypertension in the community a statement by the American society of hypertension and the International society of hypertension // J. Hypertens. — 2014. — Vol. 32, № 1. — Р. 3–15.
3. Mancia G., Fagard R., Narkiewicz K. et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) // J. Hypertens. — 2013. — Vol. 31, № 7. — Р. 281–357. doi: 10.1097/01.hjh.0000431740.32696.cc.
4. Gueyffi er F., Bulpitt C., Boissel J.P. et al. Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials. INDANA Group // Lancet. — 1999. — Vol. 353, № 9155. — P. 793–796.
5. Beckett N.S., Peters R., Fletcher A.E. et al. HYVET Study Group. Treatment of hypertension in patients 80 years of age or older // N. Engl. J. Med. — 2008. — Vol. 358, № 18. — P. 1887–1898.
6. Zhang Y., Zhang X., Liu L., Zanchetti A. Is a systolic blood pressure target < 140 mmHg indicated in all hypertensives? Subgroup analyses of fi ndings from the randomized FEVER trial // Eur. Heart J. — 2011. — Vol. 32, № 12. — P. 1500–1508.
7. SHEP Co-operative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP) // J. Am. Med. Assoc. — 1991. — Vol. 265, № 24. — P. 3255–3264.
8. Dahlof B., Lindholm L.H., Hansson L., Schersten B., Ekbom T., Wester P.O. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension) // Lancet. — 1991. — Vol. 338, № 8778. — P. 1281–1285.
9. Amery A., Birkenhager W., Brixko P. et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial // Lancet. — 1985. — Vol. 1, № 8442. — P. 1349–1354.
10. Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party // Br. Med. J. — 1992. — Vol. 304, № 6824. — P. 405–412.
11. Coope J., Warrender T.S. Randomised trial of treatment of hypertension in elderly patients in primary care // Br. Med. J. — 1986. — Vol. 293, № 6555. — P. 1145–1151.
12. Staessen J.A., Fagard R., Thijs L. et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators // Lancet. — 1997. —Vol. 350, № 9080. — P. 757–764.
13. Liu L., Wang J.G., Gong L., Liu G., Staessen J.A. Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group // J. Hypertens. — 1998. — Vol. 16, № 12, Pt. 1. — P. 1823–1829.
14. Hansson L., Lindholm L.H., Ekbom T. et al. Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study // Lancet. — 1999. — Vol. 354, № 9192. — P. 1751–1756.
15. Lithell H., Hansson L., Skoog I. et al. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial // J. Hypertens. — 2003. — Vol. 21, № 5. — P. 875–886.
16. Gradman A.H., Schmieder R.E., Lins R.L., Nussberger J., Chiang Y., Bedigian M.P. Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive effi cacy and placebo-like tolerability in hypertensive patients // Circulation. — 2005. — Vol. 111, № 8. — P. 1012–1018.
17. Sundstrom J., Neovius M., Tynelius P., Rasmussen F. Association of blood pressure in late adolescence with subsequent mortality: cohort study of Swedish male conscripts // Br. Med. J. — 2011. — Vol. 342. — d643.473.
18. Blood Pressure Lowering Treatment Trialists’ Collaboration. Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials // Eur. Heart J. — 2008. — Vol. 29, № 21. —P. 2669–2680.
19. Kaaja R., Kujala S., Manhem K. et al. Effects of sympatholytic therapy on insulin sensitivity indices in hypertensive postmenopausal women // Int. J. Clin. Pharmacol. Ther. — 2007. — Vol. 45, № 7. — Р. 394–401.
20. Chrisp P., Faulds D. Moxonidine. A review of its pharmacology, and therapeutic use in essential hypertension // Drugs. — 1992. — Vol. 44, № 6. — P. 993–1012.
21. Haenni A., Lithell H. Moxonidine improves insulin sensitivity in insulin-resistant hypertensives // J. Hypertens. — 1999. — Vol. 17, Suppl. 3. — P. 29–35.
22. Kaan E.C., Bruckner R.et al. Effects of agmantine and moxonidine on glucose metabolism: an integrated approach towards pathophysiological mechanisms in cardiovascular metabolic disorders // Cardiovasc. Risc Factors. — 1995. — Vol. 5, Suppl. 1. — P. 19–27.
23. James P.R., Nelson-Piercy C. Management of hypertension before, during, and after pregnancy // Heart. — 2004. — Vol. 90, № 12. — P. 1499–1504.
24. Regitz-Zagrosek V., Blomstrom Lundqvist C., Borghi C. et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC) // Eur. Heart J. — 2011. — Vol. 32, № 24. — Р. 3147–3197. doi: 10.1093/eurheartj/ehr218.
25. Ткачева О.Н., Шифман Е.М., Ляшко Е.С. и др. Национальные рекомендации по диагностике и лечению артериальной гипертензии у беременных. — М., 2010. — 84 c. / Tkachyova O.N., Shifman E.M., Lyashko E.S. et al. National guidelines on the diagnostics and management of arterial hypertension in pregnancy. — Moscow, 2010. — 84 p. [Russian].
26. Стрюк Р.И., Бакалов С.А., Бунин Ю.А. и др. Диагностика и лечение сердечно-сосудистых заболеваний при беременности // Российский кардиологический журнал. — 2013. — Т. 4, № 102. — 40 с. / Stryuk R.I., Bakalov S.A., Bunin Yu.A. et al. Diagnostics and management of cardiovascular diseases in pregnancy // Russian Cardiology Journal [Rossiyskii Kardiologicheskii Zhurnal]. — 2013. — Vol. 4, № 102. — 40 p. [Russian].
27. Levine R.J., Ewell M.G., Hauth J.C. et al. Should the defi nition of preeclampsia include a rise in diastolic blood pressure of ? 15 mm Hg to a level < 90 mm Hg in association with proteinuria? // Am. J. Obstet. Gynecol. — 2000. — Vol. 183, № 4. — P. 787–792.
28. Mancia G., Fagard R., Narkiewicz K. et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension // Journal of Hypertension. — 2013. — Vol. 31, № 7. — P. 1281–1357.
29. Helewa M.E., Burrows R.F., Smith J., Williams K., Brain P., Rabkin S.W. Report of the Canadian Hypertension Society Consensus Conference: 1. Defi nitions, evaluation and classifi cation of hypertensive disorders in pregnancy // CMAJ. — 1997. — Vol. 157, № 6. — P. 715–725.
30. Hofmeyr G.J., Atallah A.N., Duley L. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems // Cochrane Database Syst. Rev. — 2006. — № 3. — CD 001059.
31. Duley L., Henderson-Smart D.J., Meher S., King J.F. Antiplatelet agents for preventing pre-eclampsia and its complications // Cochrane Database Syst. Rev. — 2007. — № 2. — CD 004659.
32. Cockburn J., Moar V.A., Ounsted M., Redman C.W. Final report of study on hypertension during pregnancy: the effects of specifi c treatment on the growth and development of the children // Lancet. — 1982. — Vol. 1, № 8273. — P. 647–649.
33. Magee L.A., Cham C., Waterman E.J., Ohlsson A., von Dadelszen P. Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis // Br. Med. J. — 2003. — Vol. 327, № 7421. — P. 955–960.
34. Manolis A., Doumas M. Sexual dysfunction: the ‘prima ballerina’ of hypertension-related quality-of-life complications // J. Hypertens. — 2008. — Vol. 26, № 11. — P. 2074–2084.
35. Pickering T.G., Shepherd A.M., Puddey I. et al. Sildenafil citrate for erectile dysfunction in men receiving multiple antihypertensive agents: a randomized controlled trial // Am. J. Hypertens. — 2004. — Vol. 17, № 12, Pt. 1. — P. 1135–1142.
36. Scranton R.E., Lawler E., Botteman M. et al. Effect of treating erectile dysfunction on management of systolic hypertension // Am. J. Cardiol. — 2007. — Vol. 100, № 3. — P. 459–463.
Review
For citations:
Avdonina N.G., Korostovtseva L.S., Irtyuga O.B., Zvartau N.E., Konradi A.O. THE CHOICE OF THE ANTIHYPERTENSIVE DRUG IN SPECIAL CONDITIONS: GENDER- AND AGE-RELATED DIFFERENCES. "Arterial’naya Gipertenziya" ("Arterial Hypertension"). 2014;20(4):232-237. (In Russ.) https://doi.org/10.18705/1607-419X-2014-20-4-232-237
Views:
907
Email this article 